U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07627334) titled 'Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN' on April 09.
Brief Summary: Patients will receive in addition to standard histology analysis also the PDC- based drug screening.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Glioblastoma (GBM)
Intervention:
DIAGNOSTIC_TEST: CBmed drug screening platform
The main devices used within the drug screening process are purchased from PerkinElmer, Liconic Instruments, BioTek and Beckman Coulter Diagnostics
Recruitment Status: RECRUITING
Sponsor: Medic...